Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?

Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?

Abstract Background The management of COVID-19 in organ transplant recipients is among the most imperative, yet less discussed, issues based on their immunocompromised status along with their vast post-transplant medication regimens. No conclusive study has been published to evaluate proper anti-vir...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mojtaba Shafiekhani, Farbod Shahabinezhad, Tahmoores Niknam, Seyed Ahmad Tara, Elham Haem, Parviz Mardani, Zahra Zare, Sedigheh Jafarian, Khatereh Mirzad Jahromi, Sara Arabsheybani, Yalda Sadat Moeini, Jalile Alavi, Seyed Soroush Jalali, Maryam Salimi, Reza Shahriarirad, Seyed Ali Malekhosseini
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
COVID-19
Coronavirus disease 2019
Transplant
Tocilizumab
Remdesivir
Infectious and parasitic diseases
RC109-216
Accès en ligne:https://doaj.org/article/eac925369cb847e99d332d05592db228
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/eac925369cb847e99d332d05592db228

Documents similaires